At the Weizmann Institute of Science, researchers have found that certain cells begin the body's programmed death sequence and then pause — surviving, multiplying, and rebuilding damaged tissue in the aftermath of injury. These so-called DARE cells reveal that the boundary between dying and living is not always a threshold crossed, but sometimes a threshold held. In this biological hesitation lies both a gift — the capacity to heal — and a shadow, for cancer may have learned to linger in that same suspended moment, evading the treatments designed to end it.